Third, the interplay between DUSP1 and other phosphatases or oncogenic pathways could modulate the net impact on tumor progression, requiring a more comprehensive systems-level analysis to fully appreciate the therapeutic implications [28]. This evidence concerns the gene DUSP1 and neoplasm.